Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 316 AL 330

A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD)

Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK.

Bioorg Med Chem. 2024 Nov 1;113:117925. doi: 10.1016/j.bmc.2024.117925. Epub 2024 Sep 14.

Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial

Koychev I, Reid G, Nguyen M, Mentz RJ, Joyce D, Shah SH, Holman RR.

Alzheimers Res Ther. 2024 Oct 2;16(1):212. doi: 10.1186/s13195-024-01573-x.

Gut microbiota and Alzheimer's disease: Exploring natural product intervention and the Gut-Brain axis for therapeutic strategies

Pasupalak JK, Rajput P, Gupta GL.

Eur J Pharmacol. 2024 Dec 5;984:177022. doi: 10.1016/j.ejphar.2024.177022. Epub 2024 Oct 1.

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders

Carpi M, Mercuri NB, Liguori C.

Drugs. 2024 Nov;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3. Epub 2024 Oct 4.

β-amyloid's neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review

O'Connell A, Quinlan L, Kwakowsky A.

Pharmacol Res. 2024 Nov;209:107436. doi: 10.1016/j.phrs.2024.107436. Epub 2024 Oct 4.

Free radicals in Alzheimer's disease: From pathophysiology to clinical trial results

Viña J, Borrás C, Mas-Bargues C.

Free Radic Biol Med. 2024 Nov 20;225:296-301. doi: 10.1016/j.freeradbiomed.2024.09.051. Epub 2024 Oct 5.

Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease

Singh YP, Kumar H.

Chem Biol Drug Des. 2024 Oct;104(4):e14638. doi: 10.1111/cbdd.14638.

[Anti-Amyloid Antibody Therapy for Alzheimer's Disease]

Shinohara M, Ono K.

Brain Nerve. 2024 Oct;76(10):1119-1125. doi: 10.11477/mf.1416202747.

Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease

Lane HY, Wang SH, Lin CH.

Pharmacol Biochem Behav. 2024 Dec;245:173885. doi: 10.1016/j.pbb.2024.173885. Epub 2024 Oct 9.

Serotonin in depression and Alzheimer's disease: Focus on SSRI's beneficial effects

Tahiri J, Mian M, Aftan F, Habbal S, Salehi F, Reddy PH, Reddy AP.

Ageing Res Rev. 2024 Nov;101:102537. doi: 10.1016/j.arr.2024.102537. Epub 2024 Oct 9.

Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer's disease: current approaches and future perspectives

Chakraborty S, Vishwas S, Harish V, Gupta G, Paudel KR, Dhanasekaran M, Goh BH, Zacconi F, de Jesus Andreoli Pinto T, Kumbhar P, Disouza J, Dua K, Singh SK.

Expert Opin Drug Deliv. 2024 Dec;21(12):1771-1792. doi: 10.1080/17425247.2024.2414768. Epub 2024 Oct 13.

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial

Sen A, Toniolo S, Tai XY, Akinola M, Symmonds M, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Jones GD, Tabi Y, Maio R, Frangou E, Love S, Thompson S, Van Der Putt R, Manohar SG, McShane R, Husain M.

Epilepsia Open. 2024 Dec;9(6):2353-2364. doi: 10.1002/epi4.13070. Epub 2024 Oct 14.

Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease

Ma YN, Hu X, Karako K, Song P, Tang W, Xia Y.

Biosci Trends. 2024 Nov 15;18(5):413-430. doi: 10.5582/bst.2024.01306. Epub 2024 Oct 11.

Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease

Rosales Hernández MC, Olvera-Valdez M, Velazquez Toledano J, Mendieta Wejebe JE, Fragoso Morales LG, Cruz A.

Molecules. 2024 Oct 9;29(19):4780. doi: 10.3390/molecules29194780.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias